Argus Cognitive, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared Neurora (510 (k) K260064), a tool that gives clinicians objective behavioral measures to support the ...

The lead author of the major study told Newsweek they were "struck" by how stable autism rates remained over time.

Credit: getty Images Allison Paugh, a psychiatric mental health nurse practitioner (PMHNP), explains the assessment, diagnosis, and treatment plan for autism from early childhood to adulthood. The ...

Argus's Neurora tool is intended to complement clinicians' professional judgement rather than serve as a standalone diagnostic for autism.

– CentralReach, the leader in autism and intellectual and developmental disabilities (IDD) care software announces the establishment of its exclusive strategic partnership with Dr. Thomas Frazier’s ...

Letter: Anna Bird says the decision by some NHS integrated care boards to impose a two-year minimum wait is harmful to young people and their families ...

The review, which focuses on younger age groups, warned there was a risk society was moving from an era of under-diagnosis to over-diagnosis or mis-diagnosis.

ADHD and autism review highlights risk of misdiagnosis as cases rise - It said there is a mismatch between true rates of the ...

England-focused review led by Prof Peter Fonagy returns stark warning and calls for shift to ‘needs-led’ system ...

Reading Prof Peter Fonagy’s independent government review into mental health, ADHD and autism had me not just punching the air but weeping with gratitude. Much of what he says is manna from heaven ...